Ranbaxy Drugs Limited

Founded in 1984 and headquartered in Gujarat, India.

1984 | Vadodara, Gujarat (India) | Merged
Last Updated: January 16, 2025

Ranbaxy Drugs Profile

Key Indicators

  • Authorised Capital ₹ 100.05 Cr
  • Paid Up Capital ₹ 3.10 Cr
  • Company Age 41 Year,
  • Last Filing with ROC 31 Mar 2017

About Ranbaxy Drugs

Ranbaxy Drugs Limited (RDL) is Amalgamated company established on 31 Jan 1984 with its office registered at Vadodara, Gujarat, India and has been running since 41 Year, with a paid up capital of 3.10 Cr. According to MCA records, 3 Directors are linked to this company as of 16 Jan 2025.

Company Details

  • Location

    Vadodara, Gujarat, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address
  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U24232GJ1984PLC095288

  • Company No.

    095288

  • Company Classification

    Public Limited Indian Non-Government Company

  • Incorporation Date

    31 Jan 1984

  • Date of AGM

    07 Aug 2017

  • Date of Balance Sheet

    31 Mar 2017

  • Listing Status

    Unlisted

  • ROC Code

    Roc Ahmedabad

Industry

Pharma

Who are the key members and board of directors at Ranbaxy Drugs?

Board Members (3)

NameDesignationAppointment DateStatus
Sandeep Mehandroo Country flag representing In Director 04-Apr-2008Current
Sanjay Jerry Country flag representing In Director 07-Mar-2014Current
Meetal Sampat Country flag representing In Director 31-Aug-2015Current

Financial Performance of Ranbaxy Drugs.

Ranbaxy Drugs Limited, for the financial year ended 2016, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
Revenue from Operations
Total Assets
Profit or Loss
Net Worth
EBITDA

What is the Ownership and Shareholding Structure of Ranbaxy Drugs?

In 2017, Ranbaxy Drugs had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Ranbaxy Drugs?

Unlock and access historical data on people associated with Ranbaxy Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Ranbaxy Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ranbaxy Drugs's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Ranbaxy Drugs

Recent activity within the organization

  • Annual General Meeting

    Ranbaxy Drugs Limited last Annual general meeting of members was held on 07 Aug 2017 as per latest MCA records.

    07 Aug 2017

  • Balance Sheet

    Ranbaxy Drugs Limited has filed its annual Financial statements for the year ended 31 Mar 2017 with Roc Ahmedabad.

    31 Mar 2017

  • Director Appointment

    Meetal Sharad Sampat was appointed as a Director was appointed as a Director on 31 Aug 2015 & has been associated with this company since 9 years 5 months .

    31 Aug 2015

  • Director Appointment

    Sanjay Jerry was appointed as a Director was appointed as a Director on 07 Mar 2014 & has been associated with this company since 10 years 10 months .

    07 Mar 2014

  • Director Appointment

    Sandeep Mehandroo was appointed as a Director was appointed as a Director on 04 Apr 2008 & has been associated with this company since 16 years 9 months .

    04 Apr 2008

  • Company Incorporation

    Ranbaxy Drugs Limited was registered on 31 Jan 1984 with Roc Ahmedabad & aged 41 years as per MCA records.

    31 Jan 1984

Frequently asked questions

  • Ranbaxy Drugs Limited was incorporated on 31 Jan 1984.

  • The authorized share capital of Ranbaxy Drugs Limited is ₹ 100.05 Cr and paid-up capital is ₹ 3.10 Cr.

  • Currently 3 directors are associated with Ranbaxy Drugs Limited.

    • Sandeep Mehandroo
    • Sanjay Jerry
    • Meetal Sharad Sampat
  • As per Ministry of Corporate Affairs (Mca), the registered address of Ranbaxy Drugs Limited is Sparc Tandalja India, Vadodara, Gujarat, 390020.

  • The corporate identification number (CIN) of Ranbaxy Drugs Limited is U24232GJ1984PLC095288 and the company number is 095288 as per Ministry of Corporate Affairs (MCA).

  • The most recent Balance Sheet for Ranbaxy Drugs Limited was filed with the ROC on 31 Mar 2017.

People also Viewed

Similar Companies Based on Drug Formulation & Development